.png){kind=icon}
.png){kind=icon}
Return
Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia
.png){kind=icon}
OA
AI
DOI：10.1038/bcj.2015.13.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En
Keywords:
BCR-ABL INHIBITOR
MYELOID-LEUKEMIA
RCSD1-ABL1
RESISTANCE
AP24534
FUSION
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.